Federal grants to The Methodist Hospital Research Institute
The Methodist Hospital Research Institute in Houston, Texas received $196 million in federal grants from fiscal 2021 to 2025, across 164 awards. Its largest program was Allergy and Infectious Diseases Research, with $51.5 million. In fiscal 2025 it was awarded $51.5 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$196 million
- Awards164
- Awarded in FY 2025$51.5 million
- Largest award$9.6 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 37 | $18.5 million |
| FY 2022 | 79 | $38.2 million |
| FY 2023 | 79 | $36.9 million |
| FY 2024 | 95 | $51.3 million |
| FY 2025 | 86 | $51.5 million |
Programs that fund The Methodist Hospital Research Institute
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 33 | $51.5 million |
| Cancer Biology Research | 24 | $31.3 million |
| Cardiovascular Diseases Research | 17 | $21.3 million |
| Cancer Treatment Research | 15 | $17.2 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 16 | $16.8 million |
| Aging Research | 11 | $11.8 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 7 | $7.8 million |
| Military Medical Research and Development | 11 | $6.9 million |
| Cancer Centers Support Grants | 1 | $6.6 million |
| Cancer Detection and Diagnosis Research | 4 | $5.3 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 149 | $189 million |
| Department of Defense | 11 | $6.9 million |
| National Science Foundation | 4 | $469,545 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Dynamics of colonization and infection by multidrug-resistant pathogens in immunocompromised and critically ill patients (dynamite) | Allergy and Infectious Diseases Research | July 14, 2021 | $9.6 million |
| The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression - overall project summary bladder cancer (BC) is the second most common urologic malignancy affecting 573,278 people worldwide in 2020. Pathologically, bc is diagnosed as non-muscle-invasive (NMI) and muscle-inv | Cancer Centers Support Grants | September 22, 2022 | $6.9 million |
| Ultra-long acting transcutaneously refillable islatravir nanofluidic implant for HIV pre-exposure - abstract long-acting (LA) pre-exposure prophylactic (PREP) strategies offer the promise of improving adherence to therapeutic regimen for maximal HIV preventive efficacy. Key attributes of zero-order | Allergy and Infectious Diseases Research | April 7, 2022 | $4.5 million |
| Novel stem cell immunotherapy for mdr-tuberculosis - abstract tuberculosis (TB) kills around 2 million people each year and is a major cause of mortality from a single infectious disease worldwide. Emergence of multidrug-resistant tb (MDR) is now a major problem in more than 60 countries of the worl | Allergy and Infectious Diseases Research | June 6, 2022 | $3.8 million |
| Systematic modeling and prediction of cell-type-specific and spatiotemporal crosstalk pathways in alzheimer's disease - abstract alzheimer’s disease (AD) affects more than 50 million people worldwide but there is no clear therapeutic option for the patients. For last two decades, ad research has bee | Aging Research | May 26, 2022 | $3.1 million |
| Vascularized niche with local immunosuppression for cell replacement for type 1 diabetes - cell encapsulation technologies are poised to improve conventional islet transplantation to more effectively manage type i diabetes. Currently, lifelong whole-body immunosuppression is administered to avoid im | Diabetes, Digestive, and Kidney Diseases Extramural Research | September 13, 2022 | $3.1 million |
| Validation of a novel 3D culture platform for tnbc treatment selection - project summary the goal of this academic [houston methodist research institute (HMRI) and md anderson cancer center (MDACC)] and industrial (EMPIRI) collaborative project is to validate a novel, functional cancer diagnostic as | Cancer Detection and Diagnosis Research | September 20, 2022 | $3.0 million |
| Sudden death risk assessment and mechanistic insights in arrhythmic mitral valve prolapse using cardiac mri and circulating proteomic biomarkers - project summary: mitral valve prolapse (MVP) is a common valvulopathy affecting 2-3% of the population and nearly 200 million individuals globally. While | Cardiovascular Diseases Research | September 5, 2024 | $3.0 million |
| Molecular mechanism of virulence regulation in streptococcus pyogenes - pathogenic bacteria survive in complex and hostile environments in the host. Several host- and microbiota-derived factors curb pathogen growth during infection. Successful pathogens respond by exploiting the cues in their immedi | Allergy and Infectious Diseases Research | June 4, 2021 | $2.8 million |
| Vascularized islet transplantation niche with local immunosuppression for the treatment of type 1 diabetes - cell encapsulation technologies are poised to improve conventional islet transplantation to more effectively manage type i diabetes. Currently, lifelong whole-body immunosuppression is admini | Diabetes, Digestive, and Kidney Diseases Extramural Research | June 30, 2022 | $2.8 million |
Questions people ask
How much federal grant money does The Methodist Hospital Research Institute get?
$196 million in 164 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives The Methodist Hospital Research Institute the most?
The Department of Health and Human Services, with $189 million in 149 awards. The Department of Defense and the National Science Foundation follow.
What is The Methodist Hospital Research Institute's largest federal grant?
$9.6 million under Allergy and Infectious Diseases Research, with its first action in the period on July 14, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund The Methodist Hospital Research Institute?
Its largest are Allergy and Infectious Diseases Research, Cancer Biology Research and Cardiovascular Diseases Research.
Other grant recipients in Houston
- Baylor College of Medicine
- The Univeristy of Texas M.D. Anderson Cancer Center
- Metropolitan Transit Authority of Harris County
- University of Texas Health Science Center at Houston
- Harris County
- University of Houston System
- William Marsh Rice University
- City of Houston
Largest federal grant recipients in Texas · Federal grants in Texas